PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337624
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337624
The specialty enzymes market will touch USD 8,921.8 million, propelling at a 7.6% compound annual growth rate, by 2030. This growth can be credited to the rising utilization of such enzymes for the growth of medications, the growing requirement for non-risky organic catalysts in the diagnostics and pharma industries, and the increasing occurrence of chronic health illnesses throughout the world.
Enzymes play an important role in numerous applications in the healthcare sector from the detection of illnesses to medication manufacturing. Here, biocatalysts are developing technology for the discovery of small molecule active pharmaceutical ingredients and are utilized on a vast scale to make specialty compounds. Therefore, the growth and availability of a huge count of enzymes to biological pharmacists have made bio-catalysis a more profitable and reasonable manufacturing choice.
On the basis of application, the research & biotechnology category is estimated to advance at a substantial CAGR during the projection period. This can be because of the growth in analytic tests, the lessening in DNA sequencing prices, a surge in testing of agricultural, food & beverages, and therapeutic items, and massive medicinal players that continue fuelling research and development investments in biologics for the development of novel drug pipelines.
In 2022, on the basis of source, the microorganisms category had the highest industry value, approximately USD 3 billion, and the category is also projected to remain dominant in the future as well. This is mainly because enzymes brought out from bacterial sources result in lesser making prices and can be cultured in huge amounts within a short span of time, and also comprise greater foreseeable and manageable enzyme content.
On the basis of type, the polymerases & nucleases category is leading the industry. This is because such enzymes catalyze the synthesis of RNA and DNA, as they are crucial for all nucleic acid processing, which comprises transcription, repetition, recombination, and restoration; and these are progressively utilized in the fields of biocatalysts, pharmaceuticals, diagnostics, and biotechnology R&D. Furthermore, the increased utilization of these enzymes in progressive biotech applications like DNA sequencing and amplification is projected to fuel the industry development in this category during the projection period.
In 2022, the North American specialty enzymes market held the largest revenue share, of around 45%, and it is projected to advance at a compound annual growth rate of 7% during the projection period. This is credited to the technical developments that made enzymes obtainable across a wide variety of applications, the growth of pioneering and high-performance items, high financial development, the existence of major market players, and the rising pharmaceutical sector, in the continent.